Demonstrating Value for Biosimilars: A Conceptual Framework

Program design recommendations highlight biosimilars' value

Read more

This article identifies the factors that facilitate and inhibit the development, commercialization, and adoption of biosimilars and recommends modifications in program design that are likely to support the demonstration of the value of biosimilars for payers, providers, and patients.


Chief Medical and Scientific Officer

Want to learn more about Worldwide Clinical Trials?